Phibro Animal Health Corporation says it will request a hearing to challenge the FDA’s Center for Veterinary Medicine moving toward banning the use of carbadox in pigs over cancer concerns.
Carbadox has been in use by US pork producers for nearly four decades.
The FDA approved Carbadox in the 1970’s to control swine dysentery and bacterial swine enteritis.
FDA official think a risk assessment shows pork derived from animals treated with the drug may contain carcinogenic residue.
The FDA is not recommending consumers change food choices while regulators attempt to remove it from the marketplace, citing potential risks from a lifetime of consuming pork containing the residues.
